There were statistically significant differences in the expression of glioma grades (WHO II, WHO III, and WHO IV) (P < 0.001) [Figure 3A and B], as well as statistically significant differences among different states of isocitrate dehydrogenase (IDH) (wild type, mutant type) (P < 0.001). Here, IDH3A is linked to central nervous system cancer.